1. Home
  2. BCO vs BLLN Comparison

BCO vs BLLN Comparison

Compare BCO & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brinks Company (The)

BCO

Brinks Company (The)

HOLD

Current Price

$97.63

Market Cap

4.4B

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$109.31

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BCO
BLLN
Founded
1859
2016
Country
United States
United States
Employees
125
713
Industry
Oil Refining/Marketing
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.9B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
BCO
BLLN
Price
$97.63
$109.31
Analyst Decision
Strong Buy
Buy
Analyst Count
2
7
Target Price
$154.00
$126.71
AVG Volume (30 Days)
373.8K
758.2K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
0.95%
N/A
EPS Growth
29.20
N/A
EPS
0.77
N/A
Revenue
$3,562,300,000.00
N/A
Revenue This Year
$7.22
$46.29
Revenue Next Year
$5.92
$30.14
P/E Ratio
$125.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$85.00
$61.96
52 Week High
$136.37
$138.70

Technical Indicators

Market Signals
Indicator
BCO
BLLN
Relative Strength Index (RSI) 35.62 61.91
Support Level N/A $79.07
Resistance Level $117.36 $138.70
Average True Range (ATR) 2.63 7.52
MACD -0.33 0.36
Stochastic Oscillator 15.65 91.68

Price Performance

Historical Comparison
BCO
BLLN

About BCO Brinks Company (The)

The Brink's Co is a provider of secure logistics and security solutions for cash and other valuables. Its segments include: North America segment includes operations in the U.S. and Canada, including the Brink's Global Services (BGS) line of business; Latin America segment consists operations in Latin American countries where it has an ownership interest, including the BGS line of business; Europe segment includes total operations in European countries that provide services outside of the BGS line of business; and Rest of World segment consists operations in the Middle East, Africa and Asia. It also includes total operations in European countries that provide BGS services and BGS activity in Latin American countries. It derives maximum revenue from the North America segment.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: